International Clinical Trial: Development and Validation of a Predictive Model for Chemoradiotherapy Response and Prognosis in Mid-Low Locally Advanced Rectal Cancer Based on Transcriptomic Profiling and Clinical Characteristics

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119769) titled 'Development and Validation of a Predictive Model for Chemoradiotherapy Response and Prognosis in Mid-Low Locally Advanced Rectal Cancer Based on Transcriptomic Profiling and Clinical Characteristics' on March 3.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Taizhou Cancer Hospital

Condition: Mid-low Locally Advanced Rectal Cancer (LARC)

Intervention: Validation Set:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-03-03

Target Sample Size: Validation Set:467;Training set:467;

Countries of Recruitment: China

To know more, visit https:/...